Will Arena Pharmaceuticals, Inc. (ARNA) Stay at the Top of the Healthcare Sector?

Friday, October 08, 2021 01:37 PM | InvestorsObserver Analysts

Mentioned in this article

Will Arena Pharmaceuticals, Inc. (ARNA) Stay at the Top of the Healthcare Sector?

Arena Pharmaceuticals, Inc. (ARNA) is around the middle of the Healthcare sector according to InvestorsObserver. ARNA received an overall rating of 32, which means that it scores higher than 32% of stocks. Additionally, Arena Pharmaceuticals, Inc. scored a 63 in the Healthcare sector, ranking it higher than 63% of stocks in that sector.

ARNA has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on ARNA!

See Full ARNA Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Arena Pharmaceuticals, Inc. Stock Today?

Arena Pharmaceuticals, Inc. (ARNA) stock is up 3.08% while the S&P 500 is down -0.24% as of 1:35 PM on Friday, Oct 8. ARNA has gained $1.83 from the previous closing price of $59.51 on volume of 125,477 shares. Over the past year the S&P 500 has gained 27.34% while ARNA is down -23.33%. ARNA lost -$8.17 per share the over the last 12 months. Click Here to get the full Stock Report for Arena Pharmaceuticals, Inc. stock.